Regeneron Pharmaceuticals reported $1.71B in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Agenus AGEN:US $ 61.4M 12.89M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Alimera Sciences ALIM:US $ 16.04M 666K
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amgen AMGN:US $ 3.74B 804M
Astellas Pharma 4503:JP 317.56B 56.13B
AstraZeneca AZN:LN 10.51B 1.79B
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Eli Lilly And LLY:US $ 5405.7M 677M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Kyowa Hakko Kirin 4151:JP 70.2B 9.8B
Merk MRK:US $ 10332M 386M
Moderna Inc MRNA:US 1.84B 38M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Novartis NOVN:VX 9.96B 998M
Novartis NVS:US 9.96B 998M
Ophthotech OPHT:US $ 34.67M 1.57M
Pfizer PFE:US $ 15788M 3271M
Puma Biotechnology PBYI:US $ 46.5M 1.83M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Teva Pharmaceutical TEVA:IT 4.37B 352M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M